<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ABSTRACT: Missense mutations in the imprinted gene that encodes cyclin-dependent kinase inhibitor 1C (CDKN1C, also called p57Kip2) result in a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorder</z:e> associated with <z:hpo ids='HP_0001511'>prenatal growth retardation</z:hpo> (IMAGe syndrome) </plain></SENT>
<SENT sid="1" pm="."><plain>Loss-of-function mutations in CDKN1C have been previously described in the congenital <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndrome <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> and some <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In contrast, a recent study by Arboleda et al. proposes that the CDKN1C mutations associated with IMAGe syndrome have a gain-of-function effect </plain></SENT>
<SENT sid="3" pm="."><plain>These findings highlight how rare <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorders</z:e> can provide important insights into the regulation of critical processes such as regulation of cell growth </plain></SENT>
</text></document>